IXICO plc has signed a memorandum of understanding or MOU, with the Beijing Union Medical and Pharmaceutical General Corporation, or UMP. The MOU states that IXICO and UMP plan to work together to deploy a neuroimaging informatics platform in China to support dementia diagnosis, to advance public understanding of dementia, and to use imaging biomarkers to enrich study populations to streamline the evaluation of new dementia treatments.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7 GBX | 0.00% |
|
0.00% | -44.00% |
Jun. 19 | Ixico Bags Over GBP1 Million Contract for Parkinsonian Disorder Study | MT |
Jun. 19 | AIM WINNERS & LOSERS: Ixico and Light Science Technologies win deal | AN |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.00% | 4.4M | |
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |
- Stock Market
- Equities
- IXI Stock
- News IXICO plc
- IXICO Signs Memorandum of Understanding with Beijing Union Medical and Pharmaceutical General Corporation